Clinical Trial

EndoVascular Aortic Dissection Early vs Delayed

Study acronym: EVADE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter, non-inferior, parallel-controlled observational study. This study aims to compare clinical outcomes of endovascular treatment for acute high-risk type B aortic dissection in the acute phase versus the subacute phase. No interventions will be imposed on the patients' standard treatment. Patients with acute high-risk type B aortic dissection will be grouped based on the actual timing of their treatment.
Trial Details
NCT Number NCT07143071
Lead Sponsor Shanghai Zhongshan Hospital
Conditions Aortic Dissection Type B
Enrollment 4,068 participants
Start Date 2025-07-01
Primary Completion 2028-07-31 (estimated)
Study Completion 2030-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-27